 Connection
Kathleen Packard to Humans
This is a "connection" page, showing publications Kathleen Packard has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.161 |
|
|
|
-
Packard K, Iverson L, Ryan-Haddad A, Teply R, Wize A, Qi Y. A Synchronous Interprofessional Patient Safety Simulation Integrating Distance Health Professions Students. J Nurs Educ. 2019 Oct 01; 58(10):577-582.
Score: 0.017
-
Hilleman DE, Teply R, Packard KA. Knowledge, Perceptions, and Patterns of Fish Oil Use in Cardiac Patients. J Pharm Pract. 2020 Oct; 33(5):580-585.
Score: 0.016
-
Packard KA, Hilleman DE. Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin. Cardiovasc Ther. 2016 Dec; 34(6):415-422.
Score: 0.014
-
Packard K, Price P, Hanson A. Antipsychotic use and the risk of rhabdomyolysis. J Pharm Pract. 2014 Oct; 27(5):501-12.
Score: 0.011
-
Packard KA, Campbell JA, Knezevich JT, Davis EM. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome. Pharmacotherapy. 2012 Mar; 32(3):244-73.
Score: 0.010
-
Packard K, Herink M, Kuhlman P. Pharmacist's role in an interdisciplinary cardiac rehabilitation team. J Allied Health. 2012; 41(3):113-7, 117a, 117b.
Score: 0.010
-
Packard KA, Lenz TL, Destache CJ. Teaching heart failure treatment guidelines and assessing heart failure therapy. Am J Pharm Educ. 2010 Aug 10; 74(6):103.
Score: 0.009
-
Packard KA, Majeed F, Mohiuddin SM, Mooss AN, Hilleman DE, Arouni AJ. Low high-density lipoprotein cholesterol is associated with impaired endothelial function in Asian Indians. Ethn Dis. 2005; 15(4):555-61.
Score: 0.006
-
Packard KA, Arouni AJ, Hilleman DE, Gannon JM. Fingernail clubbing and chromonychia associated with the use of angiotensin II receptor blockers. Pharmacotherapy. 2004 Apr; 24(4):546-50.
Score: 0.006
-
Hilleman DE, Mohiuddin SM, Packard KA. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest. 2004 Feb; 125(2):435-8.
Score: 0.006
-
Packard KA, Khan MM. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol. 2003 Jul; 3(7):909-20.
Score: 0.005
-
Hilleman DE, Dunlay RW, Packard KA. Reteplase for dysfunctional hemodialysis catheter clearance. Pharmacotherapy. 2003 Feb; 23(2):137-41.
Score: 0.005
-
Hilleman DE, Reyes AP, Mooss AN, Packard KA. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery. Curr Med Res Opin. 2003; 19(5):376-82.
Score: 0.005
-
Packard KA, Backes JM, Lenz TL, Wurdeman RL, Destache C, Hilleman DE. Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease. Pharmacotherapy. 2002 Dec; 22(12):1527-32.
Score: 0.005
-
Packard KA, Wurdeman RL, Reyes AP. Constipation, polyuria, polydipsia, and edema associated with orlistat. Ann Pharmacother. 2002 Jul-Aug; 36(7-8):1168-70.
Score: 0.005
-
Packard KA, Wurdeman RL, Arouni AJ. ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction. Ann Pharmacother. 2002 Jun; 36(6):1058-67.
Score: 0.005
-
Teply RM, Packard KA, White ND, Hilleman DE, DiNicolantonio JJ. Treatment of Depression in Patients with Concomitant Cardiac Disease. Prog Cardiovasc Dis. 2016 Mar-Apr; 58(5):514-28.
Score: 0.003
-
Davis EM, Packard KA, Jackevicius CA. The pharmacist role in predicting and improving medication adherence in heart failure patients. J Manag Care Spec Pharm. 2014 Jul; 20(7):741-55.
Score: 0.003
-
DiNicolantonio JJ, Norgard NB, Meier P, Lavie CJ, O'Keefe JH, Niazi AK, Chatterjee S, Packard KA, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Bangalore S, Fuchs FD, Serebruany VL. Optimal aspirin dose in acute coronary syndromes: an emerging consensus. Future Cardiol. 2014 Mar; 10(2):291-300.
Score: 0.003
-
Ling H, Packard KA, Burns TL, Hilleman DE. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris. Am J Cardiovasc Drugs. 2013 Dec; 13(6):407-12.
Score: 0.003
-
Doll J, Packard K, Furze J, Huggett K, Jensen G, Jorgensen D, Wilken M, Chelal H, Maio A. Reflections from an interprofessional education experience: evidence for the core competencies for interprofessional collaborative practice. J Interprof Care. 2013 Mar; 27(2):194-6.
Score: 0.003
-
Davis EM, Packard KA, Knezevich JT, Campbell JA. New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome. Pharmacotherapy. 2011 Oct; 31(10):975-1016.
Score: 0.002
-
Davis EM, Packard KA, Hilleman DE. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers. Pharmacotherapy. 2010 Jul; 30(7):749, 274e-318e.
Score: 0.002
-
Chock AW, Packard KA, Ohri LK. Comment: fatal intracranial bleed potentially due to a warfarin and influenza vaccine interaction. Ann Pharmacother. 2009 Nov; 43(11):1913; author reply 1913-4.
Score: 0.002
-
Maciejewski S, Mohiuddin SM, Packard KA, Mooss AN, Reyes AP, Aryana A, Hilleman DE. Randomized, double-blind, crossover comparison of amlodipine and valsartan in african-americans with hypertension using 24-hour ambulatory blood pressure monitoring. Pharmacotherapy. 2006 Jul; 26(7):889-95.
Score: 0.002
-
Mooss AN, Wurdeman RL, Sugimoto JT, Packard KA, Hilleman DE, Lenz TL, Rovang KS, Arcidi JM, Mohiuddin SM. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J. 2004 Oct; 148(4):641-8.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|